The PAX9 antibody is a research tool targeting the PAX9 protein, a member of the paired box (PAX) transcription factor family critical in embryonic development. PAX9. encoded by the *PAX9* gene on human chromosome 14. contains a conserved DNA-binding paired domain and a homeodomain, enabling it to regulate gene expression during organogenesis. It plays pivotal roles in craniofacial development, tooth morphogenesis, and the formation of organs like the thyroid and thymus. PAX9 mutations are linked to congenital disorders, such as tooth agenesis and syndromic conditions like oligodontia.
PAX9 antibodies are widely used in developmental biology and disease research to detect PAX9 expression via techniques like immunohistochemistry (IHC), Western blotting, and immunofluorescence (IF). These antibodies help elucidate PAX9's spatiotemporal expression patterns, interactions with signaling pathways (e.g., FGF, BMP), and its role in stem cell differentiation. Commercial PAX9 antibodies are often raised against specific epitopes (e.g., N-terminal regions) and validated in human, mouse, or rat samples. Researchers prioritize antibodies with high specificity, verified through knockout controls or siRNA knockdown.
Recent studies also explore PAX9's potential in cancer (e.g., esophageal squamous cell carcinoma) and regenerative medicine. Selecting the appropriate PAX9 antibody depends on the experimental design, including host species compatibility and application requirements. Overall, PAX9 antibodies remain indispensable for decoding developmental mechanisms and disease pathologies associated with this transcription factor.